Clorox has provided its financial outlook for fiscal year 2027, projecting adjusted EPS and sales figures. The sales guidance is above analyst estimates, while the EPS range straddles the consensus, indicating a mixed but generally positive long-term outlook for the company.
Clorox (CLX) has released its financial guidance for fiscal year 2027. The company projects adjusted EPS of $5.70-$6.00, which is a mixed bag compared to the analyst estimate of $5.97, as the range includes both figures below and above the consensus. However, the sales guidance of $7.594 billion-$7.661 billion is notably above the analyst estimate of $7.501 billion. This suggests that Clorox anticipates stronger revenue growth than previously expected, which could be a positive long-term signal for the company. For traders, the key opportunity lies in the higher sales forecast, which might offset any concerns from the mixed EPS outlook, potentially leading to a neutral to slightly positive short-term reaction as the market digests the long-term projections.